Healthpeak reports $0.44 adjusted FFO and raises 2026 FFO guidance

Healthpeak reported third-quarter 2026 net income of $0.02 per share and adjusted FFO of $0.44 per share, compared with a $0.17 per-share loss and $0.46 adjusted FFO a year earlier. The company raised its 2026 adjusted FFO guidance to $1.76-$1.78 per share and same-store cash NOI growth guidance to 0.5%-2.0%, while lowering earnings guidance to $0.39-$0.41 per share due primarily to depreciation from Janus Living’s senior housing acquisitions. Healthpeak also acquired or agreed to acquire about $233 million of life science properties, entered a new $500 million term loan facility, and reported net debt of 4.7 times adjusted EBITDAre.